DOVER, Del., Oct. 22, 2025 /PRNewswire/ -- Expert Systems Inc., a leading life sciences accelerator, announced its continued support for Traws Pharma (TRAW) as the company initiates Phase 2 clinical ...
TipRanks on MSN
Philogen’s new phase 2 study: A potential game-changer in basal cell carcinoma treatment
Philogen SpA ($DE:78Q) announced an update on their ongoing clinical study. Philogen S.p.A. is conducting a Phase 2 clinical study titled ‘A Phase ...
Philogen SpA ($DE:78Q) announced an update on their ongoing clinical study. Philogen S.p.A. is conducting a Phase 2 clinical study titled ‘A Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback